Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Selling, General & Administrative (2015 - 2026)

Updated

Iovance Biotherapeutics (IOVA) reported Selling, General & Administrative of $39.27 million for Q2 2026, up 4.5% from $37.57 million a year earlier and up 0.8% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Selling, General & Administrative (2015 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Iovance Biotherapeutics' Selling, General & Administrative came in at $149.18 million, down 8.5% year-over-year; for FY2025, it came in at $152.32 million, unchanged from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 20.4% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $152.27 million in FY2024 (+43.5%), $106.1 million in FY2023 (+1.9%), $104.1 million in FY2022 (+24.4%) and $83.66 million in FY2021 (+39.0%).
  • The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative since Q1 2025.
  • Year over year, Selling, General & Administrative gained in four of the last eight quarters, with growth averaging 11.6%.
  • The high point for year-over-year Selling, General & Administrative in five years was Q2 2024 (growth of 80.5%); the low point was Q2 2023 (a decline of 16.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $38.95 million (Q1 2026), $36.4 million (Q4 2025) and $34.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 6.43 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 3.63 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -5.65 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.92 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 582.20 Mn
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn 39.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.27 Mn
Mar 31, 2026 38.95 Mn
Dec 31, 2025 36.40 Mn
Sep 30, 2025 34.56 Mn
Jun 30, 2025 37.57 Mn
Mar 31, 2025 43.80 Mn
Dec 31, 2024 42.32 Mn
Sep 30, 2024 39.34 Mn
Jun 30, 2024 39.57 Mn
Mar 31, 2024 31.39 Mn
Dec 31, 2023 29.09 Mn
Sep 30, 2023 26.96 Mn
Jun 30, 2023 21.93 Mn
Mar 31, 2023 28.12 Mn
Dec 31, 2022 26.46 Mn
Sep 30, 2022 27.89 Mn
Jun 30, 2022 26.33 Mn
Mar 31, 2022 23.41 Mn
Dec 31, 2021 23.85 Mn
Sep 30, 2021 20.89 Mn
API Access

Iovance Biotherapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IOVA&period=max&api_key=YOUR_API_KEY